GNTX
Gentex Corporation
GNTX has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID's outlook is improving, though it still trails on the overall score.
GNTX Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
GNTX's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
GNTX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.6x | $19.37 | — |
| Current | 10x | $19.37 | — |
| Cheap | 14x | $25.34 | +31% |
| Fair | 18x | $33.58 | +73% |
| Expensive | 21x | $39.62 | +105% |
Historical ranges are pointers, not guarantees.
GNTX's PE is in its cheap range at 10x. If earnings grow as analysts expect, today's price would be 9.6x next year's earnings.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
GNTX Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect GNTX's earnings to grow, with its revenue and profitability holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
GNTX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.01 | +8.2% |
| Q3 2026 | $1.86 | +9.4% |
| Q2 2026 | $1.89 | +6.8% |
| Q1 2026 | $1.78 | +4.1% |
| Q4 2025 | $1.74 | -1.1% |
| Q3 2025 | $1.70 | -9.1% |
| Q2 2025 | $1.77 | -1.1% |
| Q1 2025 | $1.71 | -9.5% |
| Q4 2024 | $1.76 | -4.3% |
GNTX has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
GNTX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $647.7M | -1.1% |
| Q2 2026 | $651.3M | -1% |
| Q1 2026 | $675.4M | +17% |
| Q4 2025 | $644.4M | +19% |
| Q3 2025 | $655.2M | +7.7% |
| Q2 2025 | $657.9M | +15% |
| Q1 2025 | $576.8M | -2.3% |
| Q4 2024 | $541.6M | -8.1% |
GNTX's revenue is growing: $648M last quarter, down 1.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 18% | -0.9 points |
| Q2 2026 | 22% | +3.7 points |
| Q1 2026 | 18% | -1.3 points |
| Q4 2025 | 19% | +2.1 points |
| Q3 2025 | 19% | -2 points |
| Q2 2025 | 18% | -2 points |
| Q1 2025 | 20% | -2.3 points |
| Q4 2024 | 17% | -6 points |
GNTX has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over GNTX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
GNTX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $64.1M | -42% |
| Q2 2026 | $165.4M | +22% |
| Q1 2026 | $120M | +7.4% |
| Q4 2025 | $99.8M | -11% |
| Q3 2025 | $111.4M | +146% |
| Q2 2025 | $135M | +39% |
| Q1 2025 | $111.8M | +14% |
| Q4 2024 | $112.7M | +5% |
GNTX has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
GNTX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
GNTX has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
GNTX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 28.9 | Oversold |
| Stochastic | 2.9 | Oversold |
GNTX's weekly RSI is 29 (oversold) and its Stochastic is 3 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
GNTX PE vs Consumer Cyclical Sector
| Metric | GNTX | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 18x | 42% below |
| PE % | 0 | 47 | 47 pts below |
GNTX is trading at 10x earnings, a 42% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
GNTX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.8 | 6.9% below |
| 20 week MA | $22.4 | 14% below |
| 50 week MA | $23.0 | 16% below |
| 100 week MA | $23.9 | 19% below |
| 200 week MA | $27.6 | 30% below |
GNTX is in a downtrend: it's below all five of its weekly moving averages, and 30% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
GNTX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.0 | $33.9 | +17% |
| 2021 | $33.9 | $34.1 | +0.8% |
| 2022 | $34.1 | $27.0 | -21% |
| 2023 | $27.0 | $32.7 | +21% |
| 2024 | $32.7 | $29.2 | -11% |
| 2025 | $29.2 | $23.5 | -20% |
| 2026 YTD | $23.5 | $19.4 | -17% |
GNTX has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.